X4 Pharmaceuticals, Inc (XFOR)

CIK 1501697 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for X4 Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Nov 4, 202610-Q0001501697-26-000089
Oct 29, 20268-K0001501697-26-000084
Oct 19, 202640001339498-26-000005
Oct 8, 20268-K0001501697-26-000081
Oct 7, 2026SCHEDULE 13G/A0000315066-26-002326
Oct 5, 202640001501697-26-000078
Oct 1, 20261440001276750-26-000008
Sep 21, 2026SCHEDULE 13G0001738048-26-000071
Sep 9, 20268-K0001501697-26-000076
Sep 8, 20268-K0001501697-26-000072
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003487
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352651
Aug 13, 202640001501697-26-000069
Aug 13, 20261440001339498-26-000003
Aug 13, 202640001501697-26-000070
Aug 13, 20261440002081729-26-000004
Aug 6, 202610-Q0001501697-26-000068
Jul 30, 2026SCHEDULE 13G0002012383-26-003133
Jul 1, 20268-K0001501697-26-000060
Jul 1, 202630001501697-26-000063
Jul 1, 202640001501697-26-000064
Jul 1, 202640001501697-26-000065
May 15, 2026SCHEDULE 13G/A0001193125-26-226568
May 14, 2026EFFECT9999999995-26-001669
May 13, 202640001501697-26-000049